US Stock MarketDetailed Quotes
ABMC AMERICAN BIO MEDICA CORP
- 0.000100
- 0.0000000.00%
15min DelayClose Jun 7 09:30 ET
4.81KMarket Cap0.01P/E (TTM)
0.000000High0.000000Low0Volume0.000100Open0.000100Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)48.10MShares0.01680052wk High-0.01P/B4.80KFloat Cap0.00000152wk Low--Dividend TTM47.95MShs Float0.100000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
AMERICAN BIO MEDICA CORP Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -2,692.31%-363K | -14.12%-768K | -481.88%-611K | 65.44%-75K | 73.15%-69K | 96.38%-13K | -39.34%-673K | 186.96%160K | -53.90%-217K | 56.37%-257K |
| Net income from continuing operations | 596.31%1.88M | -204.54%-1.41M | 2.46%-317K | -147.36%-314K | -63.27%-400K | 31.83%-379K | 41.83%-463K | -39.48%-325K | 405.53%663K | -1,066.67%-245K |
| Operating gains losses | ---2.11M | ---- | ---- | ---- | ---- | ---- | ---332K | --537K | ---- | ---- |
| Depreciation and amortization | -38.46%8K | -25.00%51K | -13.33%13K | -29.41%12K | -27.78%13K | -27.78%13K | -13.92%68K | -21.05%15K | -10.53%17K | -14.29%18K |
| Other non cash items | ---- | -90.20%15K | --0 | --0 | --0 | -87.50%15K | 71.91%153K | --0 | 3,200.00%33K | --0 |
| Change In working capital | -140.71%-138K | 442.54%620K | -134.43%-286K | 466.67%231K | 758.82%336K | 516.36%339K | -964.71%-181K | -713.33%-122K | -584.62%-63K | 92.34%-51K |
| -Change in receivables | -103.76%-7K | 248.15%440K | 75.57%-43K | 128.48%45K | 604.00%252K | 113.79%186K | -642.50%-297K | -291.11%-176K | -953.33%-158K | -208.70%-50K |
| -Change in inventory | --0 | 16.30%107K | 15.79%22K | -53.70%25K | 227.27%36K | 200.00%24K | -21.37%92K | -17.39%19K | -57.14%54K | 111.22%11K |
| -Change in prepaid assets | 854.55%83K | -160.00%-48K | -785.71%-48K | 137.50%9K | -97.78%2K | -257.14%-11K | 316.22%80K | -83.72%7K | -175.00%-24K | -37.93%90K |
| -Change in payables and accrued expense | -252.86%-214K | 317.86%122K | -900.00%-216K | 130.30%152K | 145.10%46K | 397.87%140K | 1.75%-56K | 175.00%27K | 150.77%66K | 86.56%-102K |
| -Change in other current assets | --0 | -25.00%27K | -10.00%9K | --0 | --9K | 0.00%9K | 20.00%36K | 42.86%10K | ---- | ---- |
| -Change in other current liabilities | --0 | 22.22%-28K | -11.11%-10K | --0 | ---9K | 0.00%-9K | -20.00%-36K | -28.57%-9K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -2,692.31%-363K | -14.12%-768K | -481.88%-611K | 65.44%-75K | 73.15%-69K | 96.38%-13K | -39.34%-673K | 186.96%160K | -53.90%-217K | 56.37%-257K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 247K | 0 | ||||||||
| Net business purchase and sale | --247K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --247K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 276.47%150K | -0.43%687K | 838.37%635K | -63.60%83K | -75.89%54K | -126.23%-85K | 18.76%690K | -138.91%-86K | 1,300.00%228K | -3.86%224K |
| Net issuance payments of debt | 276.47%150K | 16.44%687K | 441.40%635K | -63.60%83K | -75.89%54K | -126.23%-85K | 37.21%590K | -179.49%-186K | 1,300.00%228K | -3.86%224K |
| Net common stock issuance | ---- | --0 | ---- | ---- | ---- | ---- | -49.75%100K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 276.47%150K | -0.43%687K | 838.37%635K | -63.60%83K | -75.89%54K | -126.23%-85K | 18.76%690K | -138.91%-86K | 1,300.00%228K | -3.86%224K |
| Net cash flow | ||||||||||
| Beginning cash position | -70.43%34K | 17.35%115K | -75.61%10K | -93.33%2K | -73.02%17K | 17.35%115K | 2,350.00%98K | -32.79%41K | -86.67%30K | -89.16%63K |
| Current changes in cash | 134.69%34K | -576.47%-81K | -67.57%24K | -27.27%8K | 54.55%-15K | -180.00%-98K | -81.91%17K | 100.00%74K | 106.71%11K | 90.73%-33K |
| End cash Position | 300.00%68K | -70.43%34K | -70.43%34K | -75.61%10K | -93.33%2K | -73.02%17K | 17.35%115K | 17.35%115K | -32.79%41K | -86.67%30K |
| Free cash flow | -2,692.31%-363K | -14.12%-768K | -481.88%-611K | 65.44%-75K | 73.15%-69K | 96.38%-13K | -38.19%-673K | 186.96%160K | -49.66%-217K | 56.37%-257K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg